Delivery Order 75F40125D00013-75F40126F19002
Award Date 6/1/26
Potential Completion Date 5/31/27
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Fujifilm Irvine Scientific, Inc., a foreign-owned, for-profit manufacturer of goods. The $246,980.00 firm fixed-price contract is for the delivery of human induced pluripotent stem cell-derived (hiPSC) cells. The contract has an ultimate completion date of September 8, 2026. This order was not set aside for any specific business type. Fujifilm Irvine Scientific, Inc. specializes in providing cell...
- The U.S. Food and Drug Administration awarded a $50,095 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. for the supply of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). The contract was awarded on June 3, 2022, with a completion date of June 2, 2023, and performance is based in Jefferson, Arkansas. Fujifilm Cellular Dynamics, a subsidiary of Japan-based Fuji Photo Film Company LIMITED, specializes in the production of biologically relevant human cells...
- <p>The Food and Drug Administration awarded a purchase order to Fujifilm Cellular Dynamics, Inc. for $79,833.00 on June 7, 2023. The order is for pluripotent stem cell and electrophysiology products, with performance in Madison, Wisconsin. The firm-fixed-price purchase order carries no set-aside designation and is scheduled for completion by August 7, 2023.</p>
- This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of human induced pluripotent stem cell-derived cells. The $26,680 contract is to provide specialized cell cultures, including cardiomyocytes, neurons, astrocytes, and hepatocytes, to support the FDA's active research program. The award has no set-aside designation and is a sole-source award,...
- This is a $89,655.00 firm fixed-price purchase order awarded by the Food and Drug Administration to Fujifilm Irvine Scientific, Inc. (doing business as Irvine Scientific) for the purchase of human induced pluripotent stem cell-derived (hiPSC) cells. The contract has a completion date of June 29, 2026 and was awarded on July 1, 2025. Irvine Scientific is a manufacturer of cell culture media, reagents, and medical devices that has received prior federal contract awards to provide specialized...
- This is a $99,500.00 firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell lines. The contract is for the supply of iCell Cardiomyocytes, a specialized cell product used in biomedical research, drug development, and toxicology screening. The contract has...
- This is a $24,061 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to the foreign-owned, for-profit manufacturer Fujifilm Cellular Dynamics, Inc. The contract is for the supply of various induced pluripotent stem cell (iPSC)-derived human cell products, including cardiomyocytes, neurons, astrocytes, hepatocytes, and endothelial cells. These specialized cell lines are used in biomedical...
- This $16,375.00 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned manufacturer of specialized human cell cultures derived from induced pluripotent stem cells (iPSCs). The contract is for the delivery of iCell Cardiomyocytes, which are biologically relevant human cardiac cells used to support biomedical research and drug development...
- This is a $24,924.80 firm-fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC)-derived human cells. The contract is for the delivery of iPSC-derived dopaminergic and glutamatergic neuronal cells to support biomedical research and drug development initiatives. No...
- This is a $124,070 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC) derived human cell products. The contract is for the delivery of iPSC-derived human neurons and astrocytes, which are biologically relevant cell types used to support biomedical...
- 75F40125D00013Indefinite Delivery Contract
- 75F40125D00013-75F40126F19002Delivery Order
The Food and Drug Administration issued a $15,133 delivery order to Fujifilm Biosciences Inc. on June 1, 2026, for the purchase of human induced pluripotent stem cell-derived (hiPSC) cells. This order is issued under the FDA's single-award Indefinite Delivery Contract with Fujifilm, valued at $500,000 and running through August 31, 2031, which supports procurement of hiPSC cells and related research materials. Place of performance is Silver Spring, Maryland. Performance is scheduled to conclude on May 31, 2027. The order is priced on a firm fixed-price basis with no set-aside applied.
Generated 7/9/26, 11:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 7/7/26 |